A major advance in cancer investigation is arising with the use of mini-antibodies to reactivate mutated p53. This vital malignant suppressor protein is frequently inactivated in many forms of tumors, causing https://myeasybookmarks.com/story7638028/mini-antibodies-reactivate-p53-the-potential-pathway-for-malignant-treatment